✦ LIBER ✦

P2-400: Statins for the prevention of Alzheimer's disease and dementia

✍ Scribed by McGuinness, Bernadette; Lau, Laurence; Craig, David; Bullock, Roger; Passmore, Peter

Book ID: 122698047
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 55 KB
Volume: 4
Category: Article
ISSN: 1552-5260
DOI: 10.1016/j.jalz.2008.05.1478

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Systematic review of statins for the pre

Systematic review of statins for the prevention of vascular dementia or dementia

✍ Weerasak Muangpaisan; Carol Brayne; the Alzheimer's Society Vascular Dementia Sy 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 195 KB

Systematic review of statins for the pre

Systematic review of statins for the prevention of vascular dementia or dementia

✍ Weerasak Muangpaisan; Carol Brayne; the Alzheimer's Society Vascular Dementia Sy 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 195 KB

Statins in the prevention of dementia an

Statins in the prevention of dementia and Alzheimer's disease: A meta-analysis of observational studies and an assessment of confounding

✍ Wong, William B.; Lin, Vincent W.; Boudreau, Denise; Devine, Emily Beth 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 322 KB

Prevention of Alzheimer's disease and de

Prevention of Alzheimer's disease and dementia. Major findings from the Kungsholmen Project

✍ Laura Fratiglioni; Bengt Winblad; Eva von Strauss 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 294 KB

Guidelines for the diagnosis of dementia

Guidelines for the diagnosis of dementia and Alzheimer's disease

✍ ; The Dementia Study Group of the Italian Neurological Society 📂 Article 📅 2000 🏛 Springer Milan 🌐 English ⚖ 65 KB

The glutamatergic system and neurodegene

The glutamatergic system and neurodegeneration in dementia: preventive strategies in Alzheimer's disease

✍ Ramón Cacabelos; Masatoshi Takeda; Bengt Winblad 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 851 KB

## EPIDEMIOLOGY AND COSTS OF DEMENTIA Alzheimer's disease (AD) is a major health problem in developed countries, accounting for approximately 50±70% of all types of dementia, followed by vascular dementia (VD, 30±40%), mixed dementia (MXD, 10±15%) and other dementing illness (10±15%) (Cacabelos, 1